Back
Pros Holdings Vs. Blueprint Medicines Industry Stock Comparison
Sell
45
PRO
Pros Holdings
Last Price:
$16.57
Seasonality Move:
-3.8%
Sell
50
BPMC
Blueprint Medicines
Last Price:
$128.39
Seasonality Move:
7.99%
Sell
45
Pros Holdings (PRO)
is a Sell
Is Pros Holdings a Buy, Sell or Hold?
-
The current Pros Holdings [PRO] share price is $16.61. The Score for PRO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
PRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRO Stock Price Chart
What is Pros Holdings's stock price today?
-
The Pros Holdings share price today is $16.61The current trend is relatively stagnant and PRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $128.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
PRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.49 | Sell |
Relative Strength Index (14 RSI): | 51.93 | Buy |
Chaikin Money Flow: | 239172 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.81 - 18.59) | Sell |
Bollinger Bands (100): | (15.59 - 22.93) | Sell |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.65 | Buy |
Relative Strength Index (14 RSI): | 74.59 | Buy |
Chaikin Money Flow: | 675123 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119 - 133.06) | Buy |
Bollinger Bands (100): | (84.56 - 117) | Buy |
PRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.56 | Buy |
20-day SMA: | 16.35 | Buy |
50-day SMA: | 17.08 | Sell |
200-day SMA: | 20.35 | Sell |
8-day EMA: | 15.84 | Buy |
20-day EMA: | 16.13 | Buy |
50-day EMA: | 17.11 | Sell |
200-day EMA: | 20.63 | Sell |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 128.23 | Buy |
20-day SMA: | 128.14 | Buy |
50-day SMA: | 111.57 | Buy |
200-day SMA: | 97.6 | Buy |
8-day EMA: | 128.16 | Buy |
20-day EMA: | 125.23 | Buy |
50-day EMA: | 115.07 | Buy |
200-day EMA: | 100.77 | Buy |
Pros Holdings Earnings Growth & PRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.25 per share, and an increase next year of $0.24 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.
Pros Holdings Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |